President Donald Trump will direct his top health officials to conduct a systematic review of the childhood vaccinations ...

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive final immunogenicity and safety data from Phase 2 study, VLA15-221, of Lyme disease vaccine candidate, VLA15. The results showed ...

A Centers for Disease Control and Prevention committee voted to do away with a recommendation that all newborn babies receive ...

The CDC Advisory Committee on Immunization Practices met last week, eliminating the universal recommendation for the birth ...

Upending decades-old guidance, the Centers for Disease Control and Prevention’s vaccine advisory committee voted to no longer ...

Close to half of South Dakotans aren’t up-to-date on their flu shots or their hepatitis B vaccinations, new vaccine survey ...

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.

The FDA’s top vaccine regulator asserted in a staff email that the Covid vaccine caused at least 10 kids' deaths, but experts ...

Valneva SE (NASDAQ:VALN) saw its stock move higher on Wednesday after the company released final Phase II results for its Lyme disease vaccine candidate, VLA15, showing robust immune responses ...

A Harvard study found that the children of women who contracted COVID-19 while pregnant may be at an increased risk for ...